Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROXYCHLOROQUINE Cause Nephrolithiasis? 266 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 266 reports of Nephrolithiasis have been filed in association with HYDROXYCHLOROQUINE (HYDROXYCHLOROQUINE SULFATE). This represents 0.4% of all adverse event reports for HYDROXYCHLOROQUINE.

266
Reports of Nephrolithiasis with HYDROXYCHLOROQUINE
0.4%
of all HYDROXYCHLOROQUINE reports
0
Deaths
91
Hospitalizations

How Dangerous Is Nephrolithiasis From HYDROXYCHLOROQUINE?

Of the 266 reports, 91 (34.2%) required hospitalization.

Is Nephrolithiasis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROXYCHLOROQUINE. However, 266 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROXYCHLOROQUINE Cause?

Drug ineffective (31,057) Rheumatoid arthritis (20,110) Off label use (15,318) Drug intolerance (14,093) Pain (13,524) Joint swelling (11,353) Fatigue (11,342) Contraindicated product administered (10,557) Arthralgia (10,367) Abdominal discomfort (9,910)

What Other Drugs Cause Nephrolithiasis?

ADALIMUMAB (2,416) ETANERCEPT (1,292) INFLIXIMAB (981) METHOTREXATE (979) ABATACEPT (788) TOPIRAMATE (768) CERTOLIZUMAB PEGOL (735) RITUXIMAB (709) TOFACITINIB (699) SODIUM OXYBATE (698)

Which HYDROXYCHLOROQUINE Alternatives Have Lower Nephrolithiasis Risk?

HYDROXYCHLOROQUINE vs HYDROXYCHLOROQUINE DIPHOSPHATE HYDROXYCHLOROQUINE vs HYDROXYETHYL STARCH 130/0.4 HYDROXYCHLOROQUINE vs HYDROXYPROGESTERONE HYDROXYCHLOROQUINE vs HYDROXYPROGESTERONE CAPROATE HYDROXYCHLOROQUINE vs HYDROXYPROPYL CELLULOSE

Related Pages

HYDROXYCHLOROQUINE Full Profile All Nephrolithiasis Reports All Drugs Causing Nephrolithiasis HYDROXYCHLOROQUINE Demographics